Reusable surgical instrument market to grow 9.1% CAGR by 2030

The reusable minimally invasive surgical instruments market is projected to rise from $2.39 billion in 2025 to $3.68 billion by 2030, driven by more minimally invasive procedures, outpatient surgeries and pressure to cut waste and costs. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Reusable minimally invasive surgical instruments are gaining share as hospitals and surgical centers look for tools that can be sterilized, reused and kept in service across many procedures. - The market’s projected rise to $3.68 billion by 2030 signals continued demand for lower-cost surgical equipment and for products that support reduced medical waste. - Growth in the category tracks broader shifts toward minimally invasive surgery, which can reduce tissue injury, complications and recovery time.

What happened: - The reusable minimally invasive surgical instruments market is projected to increase from $2.39 billion in 2025 to $2.6 billion in 2026. - The market is forecast to reach $3.68 billion by 2030, implying a 9.1% CAGR from 2026 to 2030. - The Business Research Company published the forecast in its Reusable Minimally Invasive Surgical Instruments Global Market Report 2026. - The report was issued Sept. 22, 2026.

The details: - Reusable minimally invasive surgical instruments are designed for minimally invasive surgeries and can be sterilized and reused after each operation. - Common materials include stainless steel, titanium and advanced polymers. - The tools are built to withstand repeated cleaning and sterilization cycles. - The main function is to support precise interventions while minimizing harm to surrounding tissues. - The historical market growth rate for 2025 to 2026 was 8.8%. - The report links earlier growth to more minimally invasive procedures, preference for economical surgical tools, advances in materials, better healthcare infrastructure and wider adoption of laparoscopic and endoscopic techniques. - The forecast period is supported by demand for reusable medical equipment, more outpatient surgeries, growth in specialized surgical centers, higher investment in surgical technologies and a stronger focus on reducing waste and operating costs. - Forceps, scissors, graspers and retractors are among the reusable instruments used in these procedures. - Stainless steel instruments are becoming more widely preferred because of durability and compatibility with advanced sterilization processes.

Between the lines: - The market outlook reflects a push by providers to lower per-procedure costs without sacrificing performance. - The category also benefits from the economics of outpatient care, where faster turnover and lower overhead reward durable instruments that can be used repeatedly. - The procedural shift is already visible in the numbers: the American Academy of Facial Plastic and Reconstructive Surgery reported that about 83% of all medical procedures in 2023 were minimally invasive, with 17% traditional surgeries. - The American Society of Plastic Surgeons said cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. - The regional split suggests maturity in North America and faster adoption ahead in Asia-Pacific.

What's next: - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 edition includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The company is offering a free sample and full report through the links provided in the release: Download a free sample and View the full report.

The bottom line: - Reusable minimally invasive surgical instruments are moving from a niche purchase to a core efficiency play for healthcare systems focused on cost, throughput and waste reduction.